Related Experiment Video
Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Treatable traits in children with bronchiectasis
Joséphine Annereau1, Apolline Gonsard2, Rola Abou Taam3
1Department of Paediatric Pulmonology and Allergology, AP-HP, University Hospital Necker-Enfants Malades, F-75015 Paris, France; Université Paris Cité, Inria, Inserm, HeKA, F-75015 Paris, France.
Insights
The treatable traits (TT) approach identifies modifiable factors in pediatric bronchiectasis. Further research is needed to support these traits specifically in children.
Area of Science:
- Pediatric Pulmonology
- Precision Medicine
Background:
- Bronchiectasis in children is a complex chronic respiratory condition.
- Standardized management is crucial, with international guidelines improving consistency.
- The treatable traits (TT) approach offers a precision-medicine framework.
Purpose of the Study:
- To identify potential treatable traits (TT) in pediatric bronchiectasis.
- To assess the evidence base for these TT in children.
- To guide systematic assessment and future research.
Main Methods:
- Comprehensive literature review.
- Identification of potential TT across etiological, pulmonary, extrapulmonary, and behavioral/environmental domains.
- Assessment of the evidence level for each TT in pediatric populations.
Main Results:
- Identified 40 potential treatable traits (TT) for pediatric bronchiectasis.
- Found limited evidence supporting many TT specifically in children.
- Much of the existing data is extrapolated from adult studies or other respiratory diseases.
Conclusions:
- The TT approach provides a dynamic framework for individualized assessment in pediatric bronchiectasis.
- There is an urgent need for pediatric-specific clinical trials to validate these traits.
- Further research is required to strengthen the evidence base for TT in this population.
Abstract:
Bronchiectasis in children is a heterogeneous, chronic respiratory condition for which standardised, evidence-based management is essential. While international guidelines have improved diagnostic and therapeutic consistency, the treatable traits (TT) approach offers a complementary precision-medicine framework aimed at identifying all clinically relevant, measurable, and modifiable factors in individual patients. Through a comprehensive literature review, we identified 40 potential TT in paediatric bronchiectasis, spanning aetiological, pulmonary, extrapulmonary, and behavioural/environmental domains. However, the level of evidence supporting many TT remains limited in children, with most data extrapolated from adults or other respiratory diseases. This framework should therefore be considered dynamic, guiding systematic assessment while emphasising the urgent need for paediatric-specific clinical trials.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Pulmonary Cycle: Exhalation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

